Andrew Bate

9.7k citations

122 papers · 6.2k indexed · 3 hit papers · h-index 34

Impact in

Toxicology top 0.01%
- Pharmacovigilance and Adverse Drug Reactions
Statistics and Probability top 0.5%
- Statistical Methods in Clinical Trials

Papers in

Toxicology 61
- Pharmacovigilance and Adverse Drug Reactions 61
Statistics and Probability 28
- Statistical Methods in Clinical Trials 23

Co-authors: Roland Orre I. Ralph Edwards Marie Lindquist Stephen Evans G. Niklas Norén Eugène van Puijenbroek Hubert G.M. Leufkens Toine C. G. Egberts
Journals: Drug Safety (35 papers)Pharmacoepidemiology and Drug Safety (14 papers)European Journal of Clinical Pharmacology (3 papers)Drug Discovery Today (3 papers)Clinical Pharmacology & Therapeutics (3 papers)
Partner nations: United Kingdom United States Sweden

In The Last Decade

Andrew Bate

116 papers receiving 6.0k citations

Hit Papers

align trajectories log scale

Quantitative signal detection using spontaneous ADR reporting 2009 · 645 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2009 Pharmacoepidemiology and Drug Safety
2002 Pharmacoepidemiology and Drug Safety
1998 European Journal of Clinical Pharmacology

Peers

Countries citing papers authored by Andrew Bate

Since Specialization

Citations

This map shows the geographic impact of Andrew Bate's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Bate with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Bate more than expected).

Fields of papers citing papers by Andrew Bate

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Bate. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Bate. The network helps show where Andrew Bate may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Andrew Bate, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andrew Bate Line = papers co-authored together Andrew Bate links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Interplay of Spontaneous Reporting and Longitudinal Healthcare Databases for Signal Management: Position Statement from the Real-World Evidence and Big Data Special Interest Group of the International Society of Pharmacovigilance Drug Safety ·高須啓之, Andrew Bate, Jackie Brown, Gianmario Candore, Rebecca E. Chandler, Tarek A. Hammad, Samantha Lane, Judith C. Maro, G. Niklas Norén, Alexandre Pariente, Mulugeta Russom, Maribel Salas, G. B. Kelley, Saad Shakir, Hyoseung Park, Koray Melikoğlu, Marco Tuccori, Eugène van Puijenbroek, Gianluca Trifirò, (unknown)	2025	3
2	Tree‐temporal scan statistics for safety signal detection in vaccine clinical trials Pharmaceutical Statistics ·François Haguinet, Fabián Tibaldi, P. Wang, Andrew Bate	2024	1
3	Updated core competencies in pharmacoepidemiology to inform contemporary curricula and training for academia, government, and industry Pharmacoepidemiology and Drug Safety ·Vicki Osborne, Amie Goodin, Joshua D. Brown, Almut G. Winterstein, Andrew Bate, Catherine Cohet, Lisa Pont, David Moeny, Olaf H. Klungel, Simone Pinheiro, John D. Seeger, K. Arnold Chan, Stanley A. Edlavitch, Hugh H. Tilson, Deborah Layton	2024	0
4	Timing Matters: A Machine Learning Method for the Prioritization of Drug–Drug Interactions Through Signal Detection in the FDA Adverse Event Reporting System and Their Relationship with Time of Co-exposure Drug Safety ·Vera Battini, Ф А Спатарь, María Antonietta Barbieri, Dian Kartikasari, Carla Carnovale, Emilio Clementi, Andrew Bate, Maurizio Sessa	2024	6
5	Developing an Artificial Intelligence-Guided Signal Detection in the Food and Drug Administration Adverse Event Reporting System (FAERS): A Proof-of-Concept Study Using Galcanezumab and Simulated Data Drug Safety ·Allan Serlachius, Israa Mahmoud, François Haguinet, Andrew Bate, Maurizio Sessa	2023	5
6	Optimizing Signal Management in a Vaccine Adverse Event Reporting System: A Proof-of-Concept with COVID-19 Vaccines Using Signs, Symptoms, and Natural Language Processing Drug Safety ·博司松村, Andrew Bate, François Haguinet, Gabriel Westman, 司郎井内, Anders Hviid, Maurizio Sessa	2023	9
7	Identifying Safety Subgroups at Risk: Assessing the Agreement Between Statistical Alerting and Patient Subgroup Risk Drug Safety ·Olivia Mahaux, Eric A. Hale, François Haguinet, Warwick Anderson, Орлова Рашида Вахидовна, Andrezza de Lemos Bezerra, A. Rahmouni, Andrew Bate	2023	5
8	Visualizations throughout pharmacoepidemiology study planning, implementation, and reporting Pharmacoepidemiology and Drug Safety ·Nicolle M. Gatto, Shirley Wang, William Murk, Firman Adrian Furqon, M. Alan Brookhart, Andrew Bate, Sebastian Schneeweiß, Jeremy A. Rassen	2022	8
9	Artificial Intelligence Based on Machine Learning in Pharmacovigilance: A Scoping Review Drug Safety ·Benjamin Kompa, Joe B. Hakim, Anil Palepu, E. Bezvushko, Michael R. Smith, Paul Bain, Stephen Woloszynek, Jeffery L. Painter, Andrew Bate, Andrew L. Beam	2022	41
10	PNS271 Automation in Routine Use for Data Collection and Processing for Scalable Faster RWE Generation Value in Health ·L. Kay Carman, Chang-Han, T Thymen Simons, Anuradha Titoria, Andrew Bate	2020	4
11	A Novel Approach to Visualize Risk Minimization Effectiveness: Peeping at the 2012 UK Proton Pump Inhibitor Label Change Using a Rapid Cycle Analysis Tool Drug Safety ·Rachel E. Sobel, William L. Blackwell, David Fram, Andrew Bate	2019	1
12	Risk of acute liver injury associated with use of antibiotics. Comparative cohort and nested case–control studies using two primary care databases in Europe Pharmacoepidemiology and Drug Safety ·Ruth Brauer, Ian Douglas, Luis A. Garcı́a Rodrı́guez, Gerald Downey, Consuelo Huerta, Francisco J. de Abajo, Andrew Bate, وحید صادقی, Mark de Groot, Raymond G. Schlienger, Robert F. Reynolds, Liam Smeeth, Olaf H. Klungel, Ana Ruigómez	2016	13
13	Good Signal Detection Practices: Evidence from IMI PROTECT Drug Safety ·A Wisniewski, Andrew Bate, Cédric Bousquet, Andreas Brueckner, Gianmario Candore, Kristina Juhlin, M. Maciá, Katrin Manlik, 蔡晓阳, Suzie Seabroke, Jim Slattery, Harry Southworth, Bharat Thakrar, Phil Tregunno, Lionel Van Holle, Michael Kayser, G. Niklas Norén	2016	106
14	A Debugger for Communicating Scala Objects Oxford University Research Archive (ORA) (University of Oxford) ·Andrew Bate, Gavin Lowe	2012	0
15	Rabbits protecting birds: Hypopredation and limitations of hyperpredation Journal of Theoretical Biology ·Andrew Bate, Frank M. Hilker	2011	14
16	Rhabdomyolysis a result of azithromycin and statins: an unrecognized interaction British Journal of Clinical Pharmacology ·Johanna Strandell, Andrew Bate, Staffan Hägg, I. Ralph Edwards	2009	41
17	The application of knowledge discovery in databases to post‐marketing drug safety: example of the WHO database Fundamental and Clinical Pharmacology ·Andrew Bate, Carole A. SULLIVAN, I. Ralph Edwards	2008	73
18	Bayesian Confidence Propagation Neural Network Drug Safety ·Andrew Bate	2007	82
19	A Bayesian recurrent neural network approach for finding dependencies in large incomplete data sets International Journal of Neural Systems ·Roland Orre, Andrew Bate, Stefan Arnborg, Daphne Coleridge	2003	2
20	Data-mining analyses of pharmacovigilance signals in relation to relevant comparison drugs European Journal of Clinical Pharmacology ·Andrew Bate, Marie Lindquist, Roland Orre, I. Ralph Edwards, R.H.B. Meyboom	2002	63

About Andrew Bate

Andrew Bate is a scholar working on Toxicology, Statistics and Probability, Health Informatics, Geriatrics and Gerontology and Computational Theory and Mathematics, having authored 122 papers that have together received 6.2k indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (61 papers), Statistical Methods in Clinical Trials (23 papers), Computational Drug Discovery Methods (20 papers), Pharmaceutical studies and practices (14 papers), Biosimilars and Bioanalytical Methods (14 papers), Health Systems, Economic Evaluations, Quality of Life (13 papers), Pharmaceutical Economics and Policy (12 papers) and Biomedical Text Mining and Ontologies (8 papers). The work is most often cited by research in Toxicology (3.5k citations), Statistics and Probability (834 citations), Computational Theory and Mathematics (1.3k citations), Geriatrics and Gerontology (259 citations) and Pharmacology (1.1k citations). Andrew Bate has collaborated with scholars based in United Kingdom, United States and Sweden. Frequent co-authors include Roland Orre, I. Ralph Edwards, Marie Lindquist, Stephen Evans, G. Niklas Norén, Eugène van Puijenbroek, Hubert G.M. Leufkens, Toine C. G. Egberts, Anders Lansner and Sten Olsson. Their work appears in journals such as Drug Safety, Pharmacoepidemiology and Drug Safety, European Journal of Clinical Pharmacology, Drug Discovery Today and Clinical Pharmacology & Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact